BioNexus Gene Lab (BGLC) Current Deferred Revenue (2021 - 2026)
BioNexus Gene Lab (BGLC) reported Current Deferred Revenue of $8416.0 for Q1 2026, down 61.68% on a YoY basis from $21964.0 in Q1 2025, and little changed sequentially from $8385.0 in Q4 2025.
BioNexus Gene Lab (BGLC) Current Deferred Revenue (2021 - 2026) Analysis & Trends
BioNexus Gene Lab (BGLC) has 6 years of Current Deferred Revenue data on file, last reported at $8416.0 in Q1 2026.
- For the quarter ending Q1 2026, Current Deferred Revenue fell 61.68% year-over-year to $8416.0; the trailing twelve-month figure through Mar 2026 stood at $8416.0 (down 61.68% YoY), and the FY2025 full-year result was $8385.0, down 91.25% from the prior year.
- Current Deferred Revenue was little changed at $8416.0 in Q1 2026, from $8385.0 in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $95879.0 in Q4 2024 to a low of $107.0 in Q1 2022.
- A 5-year average of $18453.2 and a median of $11264.0 in 2025 frame the typical range for Current Deferred Revenue.
- Across the five-year window, Current Deferred Revenue surged 14219.63% in 2023 and sank 91.25% in 2025, its largest moves.
- Tracing BGLC's Current Deferred Revenue over 5 years: stood at $23123.0 in 2022, then tumbled by 64.46% to $8218.0 in 2023, then jumped by 1066.7% to $95879.0 in 2024, then slumped by 91.25% to $8385.0 in 2025, then grew by 0.37% to $8416.0 in 2026.
- Business Quant data shows BGLC's Current Deferred Revenue at $8416.0 in Q1 2026, $8385.0 in Q4 2025, and $11264.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Linde | 237.95 Bn | 233.99 Bn | 4.26 Bn |
| 2 | Sherwin Williams | 78.17 Bn | 77.95 Bn | 2.78 Bn |
| 3 | Ecolab | 76.02 Bn | 75.37 Bn | 1.85 Bn |
| 4 | Air Products & Chemicals | 66.38 Bn | 65.43 Bn | 987.40 Mn |
| 5 | Ppg Industries | 26.02 Bn | 24.40 Bn | 1.66 Bn |
| 6 | LyondellBasell Industries | 22.51 Bn | 19.87 Bn | 701.00 Mn |
| 7 | Chemical & Mining Co Of Chile | 19.70 Bn | 15.83 Bn | 778.60 Mn |
| 8 | International Flavors & Fragrances | 19.51 Bn | 18.95 Bn | 1.02 Bn |
| 9 | DuPont de Nemours | 18.80 Bn | 18.71 Bn | 602.00 Mn |
| 10 | BioNexus Gene Lab | 2.82 Mn | -1.14 Mn | -790.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8,416.00 |
| Dec 31, 2025 | 8,385.00 |
| Sep 30, 2025 | 11,264.00 |
| Jun 30, 2025 | 11,348.00 |
| Mar 31, 2025 | 21,964.00 |
| Dec 31, 2024 | 95,879.00 |
| Sep 30, 2024 | 22,834.00 |
| Jun 30, 2024 | 5,937.00 |
| Sep 30, 2023 | 8,218.00 |
| Jun 30, 2023 | 7,094.00 |
| Mar 31, 2023 | 15,322.00 |
| Dec 31, 2022 | 23,123.00 |
| Mar 31, 2022 | 107.00 |
| Dec 31, 2021 | 77,276.00 |